(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

D DOCTOR'S DERMATOLOGICAL FORMULA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

D DOCTOR'S DERMATOLOGICAL FORMULA

ST13

US500000079363515

Class

3, 5

Filing

79363515

Registration

7265487

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

08/06/2026

Trademark type

Combined

Nice classes

3, 5

Filing date

11/11/2022

Registration date

01/09/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/09/2024

Last transaction

08/06/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

98

Owner location

GB

Examiner

SNAPP, TINA LOUISE

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a stylized, cursive, capitol letter D, with words DOCTOR'S DERMATOLOGICAL FORMULA written beneath, each word on a separate line, with the word DOCTOR'S written in larger font size than words DERMATOLOGICAL and FORMULA, which are written in the same font size.

Holders and representatives

Holders

NIRVANA BRANDS WORLDWIDE LTD
Icedrops Limited

Representatives

Scott M. Lowry Lowry Blixseth APC

Technical classification

Nice Classes

Class 3Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Skin care preparationsbody lotions and creamsfacial cleanserfacial scrubskin tonerface and eye creamsnon-medicated hand washhand creambody and face moisturizernon-medicated facial and body exfoliatorlip balmmoisturizing foot gelfoot scrubnon-medicated foot creamnon-medicated skin salvessalicylic anti-acne cream cleanser not for medical purposesfacial cleansers and lotionsanti-aging creams and lotionsSPF sun block creamslotions and spraystanning creamslotionsoils and sprayscosmetic facial masksbaby wipes impregnated with cleaning preparationsnon-medicated skin balmsmicellar water; pumice stone for personal useskin whitening creamstalcum powder; hair preparationshair sprayshair gelsnon-medicated hair mistshair waxhair dyeshair moussehair creamsshampoo and conditionershair glazehair colourantsdry shampoo; shaving and depilatory preparationsshaving gelshaving balmshaving oilshaving cream and foamshaving soappost-shave balm and geldepilatory waxdepilatory cream; personal deodorants; anti-perspirants; perfumeseau de toilette and cologne

Class 5

Medicated skin care preparationsmedicated body lotions and creamscollagen based medicated skin creamsmedicated correction creams for skin discolourationmedicated facial cleansermedicated facial scrubsmedicated skin tonersmedicated creams for the face and eyesmedicated night serumsmedicated sanitizersmedicated hand creamsmedicated anti-aging creams and lotionsmedicated facial masksmedicated skin balmsmedicated skin cleaners and medicated creams for whitening the skin; medicated lip salvesmedicated gels and creams for the feet; medicated anti-acne creams

Publications

History of USPTO decisions and trademark events.

29 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/06/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/02/2026

CHLD

CHANGE OF OWNER RECEIVED FROM IB

03/26/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/08/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/12/2024

FIMP

FINAL DISPOSITION PROCESSED

04/12/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/09/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/09/2024

GPNX

NOTIFICATION PROCESSED BY IB

10/25/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/24/2023

PUBO

PUBLISHED FOR OPPOSITION

10/24/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/04/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/04/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/04/2023

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

09/05/2023

RFNP

REFUSAL PROCESSED BY IB

08/22/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/21/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/18/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/17/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/17/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/28/2023

RFRR

REFUSAL PROCESSED BY MPU

07/27/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/22/2023

CNRT

NON-FINAL ACTION WRITTEN

06/21/2023

DOCK

ASSIGNED TO EXAMINER

06/18/2023

MAFR

APPLICATION FILING RECEIPT MAILED

02/28/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/24/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/23/2023

Continuous trademark protection

Get notified about every new filing that threatens D DOCTOR'S DERMATOLOGICAL FORMULA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.